Roche’s vamikibart shows 1-year vision gains in Phase 3 uveitic macular edema trials, offering a non-steroid alternative; see ...
Experts see opportunity for radiology groups in treating this patient population, with the occupational condition impacting ...
A clinical case report describes a nurse whose partial-thickness supraspinatus tear appeared to shrink on MRI after a ...
Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline in CST with statistical ...
Learn how CARTISTEM, a stem cell-based cartilage treatment available in South Korea, may help selected patients with stage 2–3 knee osteoarthritis, including eligibility, recovery and U.S. regulatory ...
A minimally invasive ultrasound-guided technique offers long-term relief for patients with carpal tunnel syndrome with fewer ...
Daily Mail on MSN
Scottish golf on the up thanks to an unlikely pair of aces in Michael Stewart and Sandy Scott
As iconic images of the Alfred Dunhill Links Championship were beamed across the globe, two of Scottish golf's lesser-known ...
Daily Mail on MSN
How cliff diver Aidan Heslop made comeback after 444-day back surgery recovery to win World Series
EXCLUSIVE INTERVIEW BY HARRY BAMFORTH: Heslop's journey to this platform edge on a windy but sunshine-filled September day on ...
Seniors are increasingly using holistic therapies to complement traditional medicine for aging. Treatments like red light ...
NHS GP Shruti Nathwani has explained how the nasal flu spray works compared to an injection and why it is used - it's not to do with pain or anxiety ...
Roche ( RHHBY ,RO.SW,ROG.SW) announced positive one-year results from its Phase III MEERKAT and SANDCAT studies evaluating investigational therapy vamikibart in adults with uveitic macular edema (UME) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results